# NIH Reporter #3R33DA060583-03S1

NOTRE: optimizing long-acting pre-exposure prophylaxis and medications for opioid use disorder interventions in carceral settings

**Recipient:** Not Specified

**Award Amount:** $149,764.00
**Ceiling:** $149,764.00

**Awarded:** September 16, 2026

**Identifier:** 3R33DA060583-03S1

Award for a study on long-acting injectable treatments for opioid use disorder and HIV prevention in correctional settings, focusing on protocol development and effectiveness evaluation.

### Description

This project evaluates a hybrid implementation-effectiveness study of long-acting injectable treatments for opioid use disorder and HIV prevention in correctional settings, with a focus on developing protocols, evaluating facilitation strategies, and comparing effectiveness in Maryland and Washington, DC.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11565766)